Brett Delahunt
- Pulmonary and Respiratory Medicine top 0.05%
- Prostate Cancer Diagnosis and Treatment 96
- Prostate Cancer Treatment and Research 86
- Renal cell carcinoma treatment 82
- Cancer Research top 0.2%
- Cancer Genomics and Diagnostics 37
- Rheumatology top 0.2%
- Urologic and reproductive health conditions 52
- Molecular Biology top 1%
- Renal and related cancers 75
- Oncology top 1%
-
- Bladder and Urothelial Cancer Treatments 36
- Urinary and Genital Oncology Studies 16
- Co-authors
- John R. SrigleyLars EgevadJonathan I. EpsteinPeter A. HumphreyJohn N. EbleMahul B. AminHemamali SamaratungaRodolfo Montironi
- Journals
- Nature Communications (1 paper)Journal of Clinical Oncology (1 paper)SHILAP Revista de lepidopterología (2 papers)
- Partner nations
- New ZealandAustraliaSweden
In The Last Decade
Brett Delahunt
292 papers receiving 13.9k citations
Hit Papers
Peers
Comparison fields: 5 of 163
- Pulmonary and Respiratory Medicine 10.8k
- Cancer Research 3.0k
- Rheumatology 2.0k
- Molecular Biology 5.9k
- Oncology 1.9k
Countries citing papers authored by Brett Delahunt
This map shows the geographic impact of Brett Delahunt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brett Delahunt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brett Delahunt more than expected).
Fields of papers citing papers by Brett Delahunt
This network shows the impact of papers produced by Brett Delahunt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brett Delahunt. The network helps show where Brett Delahunt may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brett Delahunt, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 2 | |
| 4 | 2024 | 0 | |
| 5 | 2023 | 3 | |
| 6 | 2022 | 3 | |
| 7 | 2022 | 5 | |
| 8 | 2022 | 27 | |
| 9 | 2022 | 1 | |
| 10 | 2021 | 12 | |
| 11 | 2020 | 30 | |
| 12 | 2020 | 12 | |
| 13 | 2020 | 24 | |
| 14 | 2019 | 2 | |
| 15 | 2019 | 10 | |
| 16 | 2018 | 151 | |
| 17 | 2017 | 17 | |
| 18 | 2017 | 3 | |
| 19 | 2017 | 117 | |
| 20 | VHL and FHIT locus loss of heterozygosity is common in all renal cancer morphotypes but differs in pattern and prognostic significance. | 2001 | 47 |
About Brett Delahunt
Brett Delahunt is a scholar working on Pulmonary and Respiratory Medicine, Rheumatology and Cancer Research, having authored 300 papers that have together received 14.2k indexed citations. Recurring topics across this work include Prostate Cancer Diagnosis and Treatment (96 papers), Prostate Cancer Treatment and Research (86 papers), Renal cell carcinoma treatment (82 papers), Renal and related cancers (75 papers), Urologic and reproductive health conditions (52 papers), Cancer Genomics and Diagnostics (37 papers), Bladder and Urothelial Cancer Treatments (36 papers) and Urinary and Genital Oncology Studies (16 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (10.8k citations), Cancer Research (3.0k citations) and Rheumatology (2.0k citations). Brett Delahunt has collaborated with scholars based in New Zealand, Australia and Sweden. Frequent co-authors include John R. Srigley, Lars Egevad, Jonathan I. Epstein, Peter A. Humphrey, John N. Eble, Mahul B. Amin, Hemamali Samaratunga, Rodolfo Montironi, John N. Nacey and Peter B. Bethwaite. Their work appears in journals such as Nature Communications, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.